Article

SUNCT/SUNA and neurovascular compression: New cases and critical literature review

IRCCS Institute of Neurological Sciences of Bologna, Headache Centre, Department of Biomedical and Neuromotor Sciences, University of Bologna, Italy.
Cephalalgia (Impact Factor: 4.89). 06/2013; 33(16). DOI: 10.1177/0333102413494273
Source: PubMed

ABSTRACT

Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache with cranial autonomic symptoms (SUNA) are primary headache syndromes. A growing body of literature has focused on brain magnetic resonance imaging (MRI) evidence of neurovascular compression in these syndromes.
The objective of this article is to assess whether SUNCT is a subset of SUNA or whether the two are separate syndromes and clarify the role of neurovascular compression.
We describe three new SUNCT cases with MRI findings of neurovascular compression and critically review published SUNCT/SUNA cases.
We identified 222 published SUNCT/SUNA cases. Our three patients with neurovascular compression added to the 34 cases previously described (16.9%). SUNCT and SUNA share the same clinical features and therapeutic options. At present, there is no available abortive treatment for attacks. Lamotrigine was effective in 64% of patients; topiramate and gabapentin in about one-third of cases. Of the 34 cases with neurovascular compression, seven responded to drug therapies, 16 patients underwent microvascular decompression of the trigeminal nerve (MVD) with effectiveness in 75%.
We suggest that SUNCT and SUNA should be considered clinical phenotypes of the same syndrome. Brain MRI should always be performed with a dedicated view to exclude neurovascular compression. The high percentage of remission after MVD supports the pathogenetic role of neurovascular compression.

Download full-text

Full-text

Available from: Daniela Grimaldi
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clusterkopfschmerz, paroxysmale Hemikranie und ,,short-lasting unilateral neuralgiform headache attacks with conjuntival injection and tearing“ (SUNCT-Syndrom) werden unter den trigeminoautonomen Kopfschmerzerkrankungen (,,trigemino autonomic cephalalgia; TAC) zusammengefasst. Die neue vorgeschlagene internationale Klassifikation der Kopfschmerzerkrankungen (ICDH-3 beta) zählt nun auch die Hemicrania continua zu dieser Gruppe, außerdem wurden die Diagnosekriterien der anderen TACs modifiziert. TACs sind durch ständige oder in Attacken auftretende Kopfschmerzen mit zusätzlichen kranial autonomen Begleitsymptomen charakterisiert. Sie unterscheiden sich in ihrer Attackendauer und müssen wegen unterschiedlicher pharmakologischer Therapiestrategien voneinander abgegrenzt werden.
    No preview · Article · Dec 2013 · Der Nervenarzt
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND AND OBJECTIVES: SUNCT syndrome (short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing syndrome) is described as unilateral orbitary, supraorbitary or temporal pain, characterized as stabbing or throbbing, severe, disabling, of short duration, varying from 5 to 240 seconds. This is a difficult to treat syndrome, however in our case there has been satisfactory analgesia with intravenous lidocaine.CASE REPORT: Female patient, 32 years old, with SUNCT syndrome secondary to pituitary tumor (submitted to transsphenoidal hypophysectomy and radio-surgery), started presenting 30 daily pain crises. There has been no analgesic response to surgical procedure. Pharmacological treatment was started with lamotrigine, chlorpromazine and amitriptyline without pain relief. Patient was submitted to intravenous lidocaine infusion cycles with adequate pain relief.CONCLUSION: In this case of SUNCT syndrome, intravenous lidocaine was able to promote adequate and long-lasting analgesia and may be considered integral part of the treatment of this syndrome.
    Full-text · Article · Dec 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Medically refractory headache is an uncommon but difficult-to-treat clinical problem. Patients who fail maximal medical management may be candidates for invasive treatment. In this review, we critically examine the literature on the range of surgical treatments currently available for migraine, trigeminal autonomic cephalalgias, idiopathic intracranial hypertension and Chiari malformation type 1, with particular attention to patient selection, treatment efficacy, and complications.
    No preview · Article · Feb 2014 · Headache The Journal of Head and Face Pain
Show more